Comparison 10. Brentuximab vedotin vs. physician's choice (MTX or bexarotene).
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
10.1 Complete response | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Subtotals only | |
10.2 Objective response rate | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Subtotals only |